(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LAXOSTERONE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

LAXOSTERONE

ST13

US500000085773038

Class

1

Filing

85773038

Registration

4472210

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

33

Latest update

01/20/2024

Trademark type

Word

Nice classes

1

Filing date

11/06/2012

Registration date

01/21/2014

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/20/2024

Last transaction

01/20/2024

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

05/16/2013

First use in commerce

05/16/2013

Drawing code

4

Owner type

03

Owner location

SHANGHAI, CN

Examiner

LINCOSKI JR,JOHN T

Law office

M60

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

SYNMR BIOTECHNOLOGY (SHANGHAI) LIMITED
BESTCOM (WUXI) BIOTECH CO., LTD.
Shanghai Yongyi Biotechnology Co., Ltd.

Representatives

L. S. VanLandingham III

Technical classification

Nice Classes

Class 1

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemical compoundslaxogenin and 5alpha-hydroxy-laxogenin for use in the manufacture of dietary supplements and pharmaceuticalsfor use in research and development by biotechnology companiesuniversities and research institutions

Publications

History of USPTO decisions and trademark events.

33 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

01/20/2024

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

01/20/2024

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

01/20/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/20/2024

E89R

TEAS SECTION 8 & 9 RECEIVED

07/21/2023

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

01/21/2023

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

04/25/2019

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

04/25/2019

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/25/2019

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/28/2019

ES8R

TEAS SECTION 8 RECEIVED

03/28/2019

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

01/21/2019

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

02/21/2018

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

09/07/2016

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/08/2016

R.PR

REGISTERED-PRINCIPAL REGISTER

01/21/2014

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

12/19/2013

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

12/18/2013

ALIE

ASSIGNED TO LIE

12/16/2013

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

11/21/2013

DOCK

ASSIGNED TO EXAMINER

11/21/2013

SUPC

STATEMENT OF USE PROCESSING COMPLETE

11/20/2013

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

11/18/2013

IUAF

USE AMENDMENT FILED

10/17/2013

EISU

TEAS STATEMENT OF USE RECEIVED

10/17/2013

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

06/18/2013

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/23/2013

PUBO

PUBLISHED FOR OPPOSITION

04/23/2013

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/03/2013

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/12/2013

DOCK

ASSIGNED TO EXAMINER

03/04/2013

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/13/2012

NWAP

NEW APPLICATION ENTERED

11/09/2012

Continuous trademark protection

Get notified about every new filing that threatens LAXOSTERONE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.